Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 749.36M | 756.48M | 818.08M | 754.20M | 610.97M | 482.03M |
Gross Profit | 200.86M | 195.49M | 222.44M | 151.35M | 116.70M | 120.58M |
EBITDA | 36.63M | 13.70M | 104.86M | 42.96M | 19.44M | 34.19M |
Net Income | 11.29M | -10.12M | 34.62M | 6.80M | 592.00K | 10.93M |
Balance Sheet | ||||||
Total Assets | 0.00 | 502.89M | 527.88M | 468.10M | 440.88M | 375.16M |
Cash, Cash Equivalents and Short-Term Investments | 0.00 | 127.51M | 81.30M | 24.52M | 21.16M | 77.59M |
Total Debt | 31.13M | 16.80M | 56.65M | 17.75M | 2.31M | 1.88M |
Total Liabilities | 58.29M | 230.96M | 289.09M | 267.23M | 249.31M | 181.61M |
Stockholders Equity | 279.75M | 271.93M | 238.79M | 200.88M | 191.56M | 193.55M |
Cash Flow | ||||||
Free Cash Flow | 85.63M | 78.22M | 46.26M | -10.36M | -47.41M | 58.32M |
Operating Cash Flow | 104.33M | 97.71M | 63.24M | 15.02M | -27.04M | 66.21M |
Investing Cash Flow | -23.43M | -23.78M | -21.31M | -25.39M | -31.38M | -10.22M |
Financing Cash Flow | -40.64M | -27.45M | 15.12M | 17.57M | -3.58M | -15.59M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | 714.07M | 29.54 | 10.57% | 0.84% | 22.09% | -5.26% | |
76 Outperform | 1.75B | 29.28 | 12.60% | 0.20% | 6.08% | -23.93% | |
68 Neutral | $1.03B | 4,815.91 | 4.36% | ― | -7.67% | 7.66% | |
58 Neutral | 1.71B | -15.84 | -41.60% | ― | 26.37% | 38.13% | |
49 Neutral | 365.35M | -471.27 | -0.36% | 1.00% | 8.33% | 99.75% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
On September 3, 2025, Daktronics, Inc. held its Annual Meeting of Stockholders, where the 2025 Stock Incentive Plan was approved, replacing the 2020 Plan. The meeting also saw the election of directors, approval of executive compensation, and ratification of Deloitte & Touche, LLP as the independent registered public accounting firm for the 2026 fiscal year. The approval of the 2025 Plan is expected to facilitate future equity grants, impacting the company’s operational flexibility and stakeholder engagement.
The most recent analyst rating on (DAKT) stock is a Buy with a $18.50 price target. To see the full list of analyst forecasts on Daktronics stock, see the DAKT Stock Forecast page.